GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Liraglutide

Company
Cedars-Sinai Medical Center
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
25 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

25 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Find a Clinical Trial Near Me

See recruiting studies for Liraglutide and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03087032

    Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)

    Not yet reported The First Affiliated Hospital of Xiamen University 164 participants Est. completion 2025-02-10 1 site Stand-alone
    Type 2 diabetes Other conditions: Overweight and Obesity, Hyperglycaemia (Diabetic)
    View official trial listing →
  • Recruiting NCT NCT03878706

    The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination

    University of Athens 240 participants Est. completion 2027-06-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT03883412

    Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)

    Not yet reported University of Virginia 60 participants Est. completion 2027-12 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT04575844

    Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome

    Not yet reported University of Virginia 80 participants Est. completion 2027-04-30 1 site Stand-alone
    Metabolic syndrome
    View official trial listing →
  • Recruiting NCT NCT05268237

    Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus

    Not yet reported, Not yet reported Biolingus 15 participants Est. completion 2026-03 1 site Stand-alone
    Other conditions: Diabete Type 2
    View official trial listing →
  • Recruiting NCT NCT05390892

    PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

    Not yet reported Brigham and Women's Hospital 6000 participants Est. completion 2029-03-01 36 sites
    Cardiovascular disease Other conditions: Type2Diabetes
    View official trial listing →
  • Recruiting NCT NCT05681299

    Effects of GH and Lirglutide on AgRP

    Not yet reported Columbia University 40 participants Est. completion 2028-04-30 1 site
    Other conditions: Healthy, Growth Hormone Deficiency
    View official trial listing →
  • Recruiting NCT NCT05925959

    Preoperative Weight Loss for Open Abdominal Wall Reconstruction

    Not yet reported Benjamin T. Miller 258 participants Est. completion 2027-06-01 2 sites
    Other conditions: Abdominal Wall Hernia
    View official trial listing →
  • Recruiting NCT NCT06361238

    Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery

    Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 260 participants Est. completion 2028-03-31 1 site Stand-alone
    Other conditions: Delirium, Postoperative
    View official trial listing →
  • Recruiting NCT NCT06374875

    Fibrosis Lessens After Metabolic Surgery

    Not yet reported The Cleveland Clinic 120 participants Est. completion 2029-12-31 22 sites
    MASLDMASH Other conditions: Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, Obesity
    View official trial listing →
  • Recruiting NCT NCT06686134

    Comprehensive Clinical Evaluation Study of GLP-1RA

    LI YAN 492 participants Est. completion 2026-07-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT06720246

    Impact of Bariatric Surgery and Liraglutide on Cognitive-Behavioral Markers of Long-Term Weight Loss in Obesity

    I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 50 participants Est. completion 2027-05-01 1 site
    Other conditions: Obesity and Overweight
    View official trial listing →
  • Recruiting NCT NCT06726577

    TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis

    Not yet reported, Not yet reported Talengen Institute of Life Sciences, Shenzhen, P.R. China. 60 participants Est. completion 2027-04 1 site
    Other conditions: Amyotrophic Lateral Sclerosis
    View official trial listing →
  • Recruiting NCT NCT06742710

    Liraglutide Treatment in Obese Infertile PCOS Women

    Not yet reported Peking University Third Hospital 890 participants Est. completion 2029-12-31 3 sites Stand-alone
    Other conditions: PCOS, Obesity, Infertility
    View official trial listing →
  • Recruiting NCT NCT06836284

    The Evira Study: Additional Support During Obesity Treatment

    Not yet reported Karolinska Institutet 40 participants Est. completion 2027-05-01 3 sites
    Other conditions: Childhood Obesity, Treatment Adherence
    View official trial listing →
  • Recruiting NCT NCT06903923

    Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy

    Not yet reported University of Virginia 120 participants Est. completion 2030-04-30 1 site
    Other conditions: Obesity in Children, Bone Strength, GLP - 1, Lifestyle Modification, Bone Density, Obesity
    View official trial listing →
  • Recruiting NCT NCT06976619

    The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes

    Not yet reported Mayo Clinic 60 participants Est. completion 2029-03-31 1 site
    Type 2 diabetes Other conditions: Type 1 Diabetes
    View official trial listing →
  • Recruiting NCT NCT07029009

    Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)

    Not yet reported Mansa 50 participants Est. completion 2027-01 1 site Stand-alone
    Other conditions: Maturity Onset Diabetes of the Young
    View official trial listing →
  • Recruiting NCT NCT07042672

    Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity

    Haukeland University Hospital 80 participants Est. completion 2028-12-31 1 site
    Other conditions: Binge Eating Disorder Associated With Obesity, Binge Eating Disorder, Eating Disorder Binge, Eating Disorders, GLP-1, CBT, Obesity &Amp; Overweight
    View official trial listing →
  • Recruiting NCT NCT07094568

    Tirzepatide vs Liraglutide in Bone

    National and Kapodistrian University of Athens 72 participants Est. completion 2026-12-30 1 site
    Other conditions: Obesity (Disorder)
    View official trial listing →
  • Recruiting NCT NCT07107334

    A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia

    Not yet reported University of Florida 20 participants Est. completion 2029-11 1 site Stand-alone
    Other conditions: Endometrioid Endometrial Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07225816

    Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)

    Not yet reported Novo Nordisk A/S 71 participants Est. completion 2027-01-06 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Recruiting NCT NCT07244003

    Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 430 participants Est. completion 2028-06-30 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT07309094

    Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

    Cardenal Herrera University 250 participants Est. completion 2028-12-31 1 site
    Chronic kidney diseaseType 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Recruiting NCT NCT07702461

    Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

    Ohio State University 300 participants Est. completion 2027-01 1 site
    Other conditions: Obesity & Overweight, Diabetes (DM)
    View official trial listing →
  • Completed NCT NCT00154401

    Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 177 participants Est. completion 2005-10 39 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00154414

    Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 226 participants Est. completion 2006-05 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT00294723

    To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c

    Not yet reported Novo Nordisk A/S 746 participants Est. completion 2008-11 117 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00318422

    Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 1041 participants Est. completion 2007-05 127 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00318461

    To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together

    Not yet reported Novo Nordisk A/S 1091 participants Est. completion 2008-11 190 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00331851

    Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 584 participants Est. completion 2007-04 116 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00333151

    Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 576 participants Est. completion 2007-08 89 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00393718

    Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 400 participants Est. completion 2008-05 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00395746

    Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 264 participants Est. completion 2008-05 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00422058

    The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes

    Not yet reported Novo Nordisk A/S 564 participants Est. completion 2009-04-30 19 sites Stand-alone
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Completed NCT NCT00518882

    Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 467 participants Est. completion 2009-04 125 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00614120

    Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 929 participants Est. completion 2009-02 50 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00620282

    The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 49 participants Est. completion 2010-05 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00696657

    A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide

    Not yet reported Novo Nordisk A/S 415 participants Est. completion 2009-02-05 77 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00700817

    The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 665 participants Est. completion 2010-06 166 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00761540

    To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo

    Not yet reported Novo Nordisk A/S 37 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT00781937

    Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance

    Not yet reported Novo Nordisk A/S 422 participants Est. completion 2010-09-01 37 sites Stand-alone
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Completed NCT NCT00856986

    The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 987 participants Est. completion 2010-11 233 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00873223

    Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir

    Not yet reported Novo Nordisk A/S 33 participants Est. completion 2009-09 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00943501

    Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 21 participants Est. completion 2011-09 20 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00978393

    A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers

    Not yet reported Novo Nordisk A/S 49 participants Est. completion 2011-06-08 1 site Stand-alone
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Completed NCT NCT00983021

    Safety and Tolerability of NN9068 in Healthy Male Volunteers

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT00993304

    A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics

    Not yet reported Novo Nordisk A/S 20 participants Est. completion 2010-12 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00993720

    Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes

    Not yet reported, Not yet reported Hvidovre University Hospital 30 participants Est. completion 2010-10 1 site Stand-alone
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01029886

    Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes

    Not yet reported AstraZeneca 912 participants Est. completion 2011-04 108 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01117350

    Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure

    Not yet reported Sanofi 978 participants Est. completion 2013-03 136 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01128894

    A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

    Not yet reported GlaxoSmithKline 841 participants Est. completion 2011-09 173 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01175473

    Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes

    Not yet reported Sanofi 148 participants Est. completion 2010-11 7 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01179048

    Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results

    Not yet reported Novo Nordisk A/S 9341 participants Est. completion 2015-12-17 428 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT01206101

    Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation

    Not yet reported Novo Nordisk A/S 3 participants Est. completion 2013-06-03 16 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01208012

    Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus

    Not yet reported ikfe-CRO GmbH 44 participants Est. completion 2010-11 1 site Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01212133

    A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India

    Novo Nordisk A/S 1386 participants Est. completion 2012-04 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01226966

    Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes

    Novo Nordisk A/S 3152 participants Est. completion 2013-11 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01232946

    Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake

    Not yet reported Indiana University 30 participants Est. completion 2017-09-08 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01234649

    Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)

    Not yet reported Woman's 153 participants Est. completion 2019-06-14 1 site Stand-alone
    Type 2 diabetesMetabolic syndromePrediabetes Other conditions: Gestational Diabetes Mellitus, Disorder of Glucose Regulation
    View official trial listing →
  • Completed NCT NCT01237119

    Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis

    Not yet reported University of Birmingham 52 participants Est. completion 2014-07 1 site Stand-alone
    MASH
    View official trial listing →
  • Completed NCT NCT01270789

    LIraglutide and Beta-cell RepAir (LIBRA) Study

    Not yet reported Mount Sinai Hospital, Canada 63 participants Est. completion 2014-05 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01272219

    Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes

    Not yet reported Novo Nordisk A/S 3731 participants Est. completion 2015-03-02 226 sites Stand-alone
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Completed NCT NCT01272232

    Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes

    Not yet reported Novo Nordisk A/S 846 participants Est. completion 2013-01-25 161 sites Stand-alone
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Completed NCT NCT01288326

    Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes

    Novo Nordisk A/S 254 participants Est. completion 2013-03 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01296412

    Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)

    Not yet reported Merck Sharp & Dohme LLC 653 participants Est. completion 2012-02-29
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01299012

    Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus

    University at Buffalo 30 participants Est. completion 2013-06
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01319240

    Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2011-05 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01336023

    Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 1663 participants Est. completion 2012-11-22 302 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01345734

    Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 Diabetes

    Novo Nordisk A/S 1056 participants Est. completion 2013-07-26 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01363609

    Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes

    Not yet reported Amsterdam UMC, location VUmc 50 participants Est. completion 2015-01 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01373450

    Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)

    Not yet reported Merck Sharp & Dohme LLC 12 participants Est. completion 2011-07 Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01388361

    Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

    Not yet reported Novo Nordisk A/S 413 participants Est. completion 2012-07 124 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01392573

    A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 413 participants Est. completion 2012-10-04 86 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT01392898

    Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes

    Not yet reported Radboud University Medical Center 50 participants Est. completion 2014-05 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01394341

    Liraglutide Treatment to Patients With Severe Renal Insufficiency

    Not yet reported Bo Feldt-Rasmussen 40 participants Est. completion 2013-10 3 sites
    Type 2 diabetes Other conditions: End-stage Renal Disease
    View official trial listing →
  • Completed NCT NCT01399645

    Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes

    Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 35 participants Est. completion 2014-06 1 site Stand-alone
    MASLDMASHType 2 diabetes
    View official trial listing →
  • Completed NCT NCT01403025

    Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes

    Novo Nordisk A/S 4121 participants Est. completion 2015-12-28 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01425580

    Liraglutide and Heart Failure in Type 2 Diabetes

    Not yet reported Thomas Nystrom 62 participants Est. completion 2016-08 2 sites Stand-alone
    Heart failureType 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT01451905

    GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis

    Not yet reported University Hospital, Gentofte, Copenhagen 12 participants Est. completion 2012-12 1 site
    Other conditions: Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI
    View official trial listing →
  • Completed NCT NCT01455441

    The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes

    Not yet reported Tina Vilsboll 40 participants Est. completion 2014-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01460069

    The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis

    Not yet reported Annesofie Faurschou 20 participants Est. completion 2013-05 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01469351

    Identifying Potential Effects of Liraglutide on Degenerative Changes

    Not yet reported University of Aarhus 34 participants Est. completion 2013-04 1 site
    Other conditions: Alzheimers Disease
    View official trial listing →
  • Completed NCT NCT01472640

    The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus

    Not yet reported Flyvbjerg, Allan, DMSc 240 participants Est. completion 2015-10 4 sites
    Heart failure Other conditions: Hyperglycemia
    View official trial listing →
  • Completed NCT NCT01473953

    Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects

    Not yet reported Novo Nordisk A/S 31 participants Est. completion 2012-03 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01484262

    Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2

    Novo Nordisk A/S 1344 participants Est. completion 2014-10-31 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01499108

    Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes

    Not yet reported Peter Rossing 32 participants Est. completion 2014-08 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01505673

    Adding Liraglutide to High Dose Insulin: Breaking the Cycle

    Not yet reported Ildiko Lingvay 71 participants Est. completion 2016-06 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01507272

    Safety and Tolerability of Liraglutide in Healthy Male Volunteers

    Not yet reported Novo Nordisk A/S 34 participants Est. completion 1999-12 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01507285

    Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 1999-11 1 site
    Type 2 diabetes Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01507311

    Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 11 participants Est. completion 1999-12 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01507337

    Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers

    Not yet reported Novo Nordisk A/S 32 participants Est. completion 2004-06 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01507389

    Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2006-06 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01508806

    Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function

    Not yet reported Novo Nordisk A/S 30 participants Est. completion 2006-03 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01508858

    Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women

    Not yet reported Novo Nordisk A/S 21 participants Est. completion 2007-04 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01508897

    Comparison of Two Liraglutide Formulations in Healthy Volunteers

    Not yet reported Novo Nordisk A/S 22 participants Est. completion 2004-06-30 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01508923

    Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 17 participants Est. completion 2002-02 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01508949

    Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 35 participants Est. completion 2002-03 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01509742

    Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 19 participants Est. completion 2001-11 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01509755

    Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 196 participants Est. completion 2001-10 29 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01511159

    Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers

    Not yet reported Novo Nordisk A/S 32 participants Est. completion 2001-12 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01511172

    Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 145 participants Est. completion 2002-12 41 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01511185

    Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group

    Not yet reported Novo Nordisk A/S 20 participants Est. completion 2001-10 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01511198

    Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent

    Not yet reported Novo Nordisk A/S 223 participants Est. completion 2001-10 39 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Enrolling by invitation NCT NCT01511393

    An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

    Novo Nordisk A/S 6750 participants Est. completion 2039-12 1 site
    Type 2 diabetes Other conditions: Diabetes, Medullary Thyroid Carcinoma, Weight Management
    View official trial listing →
  • Completed NCT NCT01511692

    Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 43 participants Est. completion 2007-09 2 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01512108

    Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone

    Not yet reported Novo Nordisk A/S 363 participants Est. completion 2013-04-26 36 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01513525

    Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers

    Not yet reported Novo Nordisk A/S 21 participants Est. completion 2007-05 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01514487

    Comparison of Three Liraglutide Formulations in Healthy Volunteers

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2005-03-30 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01515553

    Bioequivalence of Two Liraglutide Formulations in Healthy Volunteers

    Not yet reported Novo Nordisk A/S 22 participants Est. completion 2007-04 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01515579

    Comparison of Two Liraglutide Formulations in Healthy Subjects

    Not yet reported Novo Nordisk A/S 22 participants Est. completion 2006-06 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01515592

    Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2006-04 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01516255

    Effect of Liraglutide on Heart Frequency in Healthy Volunteers

    Not yet reported Novo Nordisk A/S 64 participants Est. completion 2006-11 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT01516476

    Study of RO6807952 in Patients With Diabetes Mellitus Type 2

    Not yet reported Hoffmann-La Roche 2 participants Est. completion 2012-01 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01517555

    Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 18 participants Est. completion 2007-05 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01517568

    Metabolism and Excretion of Liraglutide in Healthy Male Volunteers

    Not yet reported Novo Nordisk A/S 7 participants Est. completion 2006-12 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01518101

    Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications

    Not yet reported Novartis Pharmaceuticals 62 participants Est. completion 2012-10 8 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01518166

    Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH

    Not yet reported Novo Nordisk A/S 70 participants Est. completion 2007-04 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01536665

    The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 45 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01541215

    Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 135 participants Est. completion 2020-05-20 185 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT01542242

    Liraglutide Use in Prader-Willi Syndrome

    Not yet reported Vancouver General Hospital 1 participants Est. completion 2013-03 1 site Stand-alone
    Type 2 diabetes Other conditions: Prader Willi Syndrome
    View official trial listing →
  • Completed NCT NCT01550653

    Liraglutide Effects on Memory in Healthy Subjects

    Not yet reported University of Luebeck 40 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01557166

    Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea

    Not yet reported Novo Nordisk A/S 359 participants Est. completion 2013-06-17 42 sites Stand-alone
    Other conditions: Metabolism and Nutrition Disorder, Obesity, Obstructive Sleep Apnoea
    View official trial listing →
  • Completed NCT NCT01558271

    A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 492 participants Est. completion 2014-05 14 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01562678

    Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI

    Not yet reported Beth Israel Deaconess Medical Center 28 participants Est. completion 2014-05 1 site
    Other conditions: Diabetes, Effects of Liraglutide Administration on Brain Activity, Weight Loss, Hunger
    View official trial listing →
  • Completed NCT NCT01572740

    Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 257 participants Est. completion 2013-03-27 23 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01575301

    DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists

    Not yet reported University of Dundee 411 participants Est. completion 2015-12-11 4 sites
    Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT01592279

    GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients

    Not yet reported Hadassah Medical Organization 124 participants Stand-alone
    Other conditions: Uncontrolled Type 1 Diabetic Patients
    View official trial listing →
  • Withdrawn NCT NCT01593137

    A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes

    Not yet reported Fundación Fernández-Cruz Est. completion 2014-12 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01595789

    The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes

    Not yet reported Haugaard, Steen Bendix, M.D., DMSc 41 participants Est. completion 2015-07 1 site
    Cardiovascular diseaseType 2 diabetes
    View official trial listing →
  • Completed NCT NCT01596504

    Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin

    Not yet reported Sanofi 142 participants Est. completion 2013-07 8 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01597531

    Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding

    Not yet reported East Carolina University 1 participants Est. completion 2014-06 1 site
    Type 2 diabetes Other conditions: Gastric Banding
    View official trial listing →
  • Completed NCT NCT01599338

    Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic Patients

    Not yet reported Centre Hospitalier Universitaire Dijon 30 participants Est. completion 2011-09 1 site Stand-alone
    Type 2 diabetes Other conditions: Overweight
    View official trial listing →
  • Completed NCT NCT01602913

    Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine

    GlaxoSmithKline 1 participants Est. completion 2012-05
    Other conditions: Depression, Postpartum
    View official trial listing →
  • Completed NCT NCT01610934

    The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)

    Not yet reported, Not yet reported University Hospital, Gentofte, Copenhagen 15 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Maturity-onset Diabetes of the Young
    View official trial listing →
  • Completed NCT NCT01612468

    Liraglutide in Type 1 Diabetes

    Not yet reported Steno Diabetes Center Copenhagen 100 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1, Overweight
    View official trial listing →
  • Completed NCT NCT01615978

    Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 15 participants Est. completion 2004-03 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01617434

    The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 451 participants Est. completion 2013-10 86 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01618162

    The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy

    Not yet reported Novo Nordisk A/S 435 participants Est. completion 2013-10-23 87 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01620463

    Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers

    Not yet reported Novo Nordisk A/S 32 participants Est. completion 2003-03 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01620476

    Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2004-03 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01620489

    Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment

    Not yet reported Novo Nordisk A/S 279 participants Est. completion 2013-08-20 97 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01624259

    A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes

    Not yet reported Eli Lilly and Company 599 participants Est. completion 2013-11 57 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01628445

    Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin

    Not yet reported University of Manitoba 52 participants Est. completion 2015-11 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01638260

    GLP-1 and Non-exercise Activity Thermogenesis in RHZ

    Not yet reported Maastricht University Medical Center 22 participants Est. completion 2013-11 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01654120

    Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics

    Not yet reported Mountain Diabetes and Endocrine Center 37 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type II
    View official trial listing →
  • Completed NCT NCT01658501

    Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

    Not yet reported PhaseBio Pharmaceuticals Inc. 593 participants Est. completion 2013-07 93 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01664247

    The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification

    Not yet reported Novo Nordisk A/S 346 participants Est. completion 2013-12-31 132 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01664676

    Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients

    Not yet reported University of Aarhus 11 participants Est. completion 2014-02 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01676116

    The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

    Not yet reported Novo Nordisk A/S 438 participants Est. completion 2014-03-11 109 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01677104

    The Microvascular Function of GLP-1 and Its Analogues

    Not yet reported Katarina Kos 63 participants Est. completion 2014-07 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01687582

    Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 10 participants Est. completion 2013-03 1 site Stand-alone
    Type 2 diabetes Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01695109

    The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers

    Not yet reported Medical University of Vienna 16 participants Est. completion 2012-03 1 site
    Other conditions: Healthy Human Male Subjects
    View official trial listing →
  • Completed NCT NCT01715428

    Liraglutide and Cardio-Metabolic Risk Markers

    University of Palermo 300 participants Est. completion 2015-12 1 site
    Other conditions: Type-2 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT01722227

    Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes

    Not yet reported University at Buffalo Est. completion 2018-05 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01722240

    Liraglutide in Type 1 Diabetes

    Not yet reported University at Buffalo 69 participants Est. completion 2019-07-29 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01722266

    Liraglutide in the Treatment of Type 1 Diabetes Mellitus

    Not yet reported University at Buffalo 72 participants Est. completion 2014-12-01 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01724060

    Effects of Obesity Treatments on Food Preferences and Metabolism

    Imperial College London 80 participants Est. completion 2017-10 2 sites
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01725126

    To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes

    Not yet reported GlaxoSmithKline 53 participants Est. completion 2013-09-12 3 sites Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01733758

    A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

    Not yet reported GlaxoSmithKline 494 participants Est. completion 2015-02 74 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01739049

    Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese

    Not yet reported Universiti Kebangsaan Malaysia Medical Centre 42 participants Est. completion 2015-01 1 site Stand-alone
    Other conditions: Binge Eating Behaviour
    View official trial listing →
  • Completed NCT NCT01740921

    GLP-1 and Microvascular Function in Type 2 Diabetes

    Not yet reported Royal Devon and Exeter NHS Foundation Trust 39 participants Est. completion 2016-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01744236

    SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies

    Not yet reported Amsterdam UMC, location VUmc 70 participants Est. completion 2015-08 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01753362

    Liraglutide In Overweight Patients With Type 1 Diabetes

    Not yet reported University at Buffalo 84 participants Est. completion 2018-02 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01755416

    Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting

    Not yet reported Albert Einstein College of Medicine 18 participants Est. completion 2015-01 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01755572

    Blood Pressure Outcomes With Liraglutide Therapy

    Not yet reported Mount Sinai Hospital, Canada 22 participants Est. completion 2014-03 1 site
    Type 2 diabetes Other conditions: Systolic Hypertension
    View official trial listing →
  • Completed NCT NCT01761318

    Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients

    Not yet reported Leiden University Medical Center 50 participants Est. completion 2016-03 1 site
    Type 2 diabetesMetabolic syndromeCardiovascular disease Other conditions: Diastolic Dysfunction, Fatty Liver
    View official trial listing →
  • Completed NCT NCT01767389

    Glucagon-like Peptide (GLP) Utilization and Safety

    GlaxoSmithKline 1 participants Est. completion 2013-12
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01779362

    RISE Adult Medication Study

    Not yet reported RISE Study Group 267 participants Est. completion 2019-08 4 sites
    PrediabetesType 2 diabetes
    View official trial listing →
  • Completed NCT NCT01782261

    Incretin Effect on the Immunological Phenotype

    Not yet reported Medical University of Graz 15 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01784965

    Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.

    Not yet reported Stanford University 69 participants Est. completion 2012-12
    Prediabetes Other conditions: Older Adults
    View official trial listing →
  • Completed NCT NCT01785043

    Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users

    Not yet reported Anna Cruceta 13 participants Est. completion 2014-09 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01787916

    52 Week Trial of Liraglutide in Type 1 Diabetes

    Not yet reported CHU de Quebec-Universite Laval 15 participants Est. completion 2015-04 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01789086

    A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years

    Not yet reported Novo Nordisk A/S 21 participants Est. completion 2014-05 1 site Stand-alone
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Status unknown NCT NCT01790308

    Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function

    Not yet reported Sun Yat-sen University 100 participants Est. completion 2015-12
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01794143

    A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

    Not yet reported GRADE Study Group 7850 participants Est. completion 2021-04-30 36 sites
    Type 2 diabetes Other conditions: Comparative Effectiveness of Glycemia-lowering Medications
    View official trial listing →
  • Completed NCT NCT01795248

    The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes

    Not yet reported Tina Vilsboll 105 participants Est. completion 2020-09 1 site Stand-alone
    Other conditions: Gestational Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01800968

    Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

    Not yet reported Duke University 300 participants Est. completion 2015-10 25 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT01821846

    Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus

    Novo Nordisk A/S 64 participants Est. completion 2017-03-08 7 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01832532

    A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks

    Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 34 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Sleep Apnea, Sleep Disordered Breathing
    View official trial listing →
  • Completed NCT NCT01836523

    The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 1398 participants Est. completion 2015-06 182 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT01843075

    Evaluating Liraglutide in Alzheimer's Disease

    Not yet reported Imperial College London 204 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Status unknown NCT NCT01845259

    Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?

    Not yet reported Psychiatric Centre Rigshospitalet 103 participants Est. completion 2017-03 1 site Stand-alone
    Prediabetes
    View official trial listing →
  • Completed NCT NCT01847313

    The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease

    Not yet reported Karl Neff 20 participants Est. completion 2015-11 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT01856790

    Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes

    Not yet reported Jennifer Sherr 15 participants Est. completion 2015-11 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01870297

    A Study of LY3025876 in Participants With Diabetes

    Not yet reported Eli Lilly and Company 72 participants Est. completion 2014-12 4 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01879917

    Liraglutide in Newly Onset Type 1 Diabetes.

    Not yet reported, Not yet reported Hvidovre University Hospital 65 participants Est. completion 2018-08 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01890993

    Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe

    Novo Nordisk A/S 952 participants Est. completion 2014-06 4 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01899430

    Polycystic Ovary Syndrome and Liraglutide

    Not yet reported University Medical Centre Ljubljana 32 participants Est. completion 2013-04 1 site Stand-alone
    Other conditions: PCOS, Obesity
    View official trial listing →
  • Completed NCT NCT01907854

    Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin

    Not yet reported Novo Nordisk A/S 407 participants Est. completion 2015-06-15 106 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01911468

    Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin

    Not yet reported University Medical Centre Ljubljana 36 participants Est. completion 2013-04 1 site
    Other conditions: PCOS, Obesity
    View official trial listing →
  • Completed NCT NCT01916174

    A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects

    Not yet reported Novo Nordisk A/S 50 participants Est. completion 2013-11 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01917656

    Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 343 participants Est. completion 2014-09-04 41 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01919489

    Liraglutide Hospital Discharge Trial

    Not yet reported Emory University 273 participants Est. completion 2020-08-30 5 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01931982

    Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.

    Not yet reported Bispebjerg Hospital 20 participants Est. completion 2014-04 1 site
    Type 2 diabetes Other conditions: Microvascular Dysfunction
    View official trial listing →
  • Terminated NCT NCT01934816

    Incretin and KATP Channels

    Not yet reported Katarina Kos 2 participants Est. completion 2015-10 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT01937598

    Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D

    Not yet reported Michael A. Nauck 16 participants Est. completion 2015-06 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01952145

    A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 557 participants Est. completion 2014-11-04 91 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT01954147

    Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus

    Not yet reported, Not yet reported Diabetes Care Center of Nanjing Military Command 100 participants Est. completion 2015-10 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01966978

    The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study

    Not yet reported University of Texas Southwestern Medical Center 157 participants Est. completion 2017-12 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01973231

    Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 404 participants Est. completion 2014-11 61 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT01974544

    Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines

    Not yet reported Pontificia Universidad Catolica de Chile 150 participants Est. completion 2016-12 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01982630

    Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)

    Not yet reported Merck Sharp & Dohme LLC 87 participants Est. completion 2014-10-03
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT02001363

    Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury

    Not yet reported Chen Wei Ren, MD 90 participants Est. completion 2016-03 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02008682

    The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 368 participants Est. completion 2014-11 25 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02014740

    Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes

    Not yet reported University of Miami 100 participants Est. completion 2017-03 1 site Stand-alone
    Type 2 diabetes Other conditions: Overweight, Obesity
    View official trial listing →
  • Status unknown NCT NCT02016846

    Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for Diabetes

    Not yet reported Rabin Medical Center 36 participants 1 site
    Other conditions: Glucocorticoid Induced Hyperglycemia
    View official trial listing →
  • Completed NCT NCT02036372

    Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 150 participants Est. completion 2017-01 3 sites Stand-alone
    Other conditions: Diabetes Mellitus Type II
    View official trial listing →
  • Completed NCT NCT02041234

    Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment

    Not yet reported Khoo Teck Puat Hospital 40 participants Est. completion 2022-06 1 site
    Other conditions: Type II Diabetes in Subjects BMI 27 to 32
    View official trial listing →
  • Completed NCT NCT02043054

    Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)

    Not yet reported University of Leicester 90 participants Est. completion 2017-09-29 1 site Stand-alone
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02055014

    Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)

    Not yet reported Sandwell & West Birmingham Hospitals NHS Trust 72 participants Est. completion 2017-03 4 sites Stand-alone
    Type 2 diabetes Other conditions: Obesity, Diabesity
    View official trial listing →
  • Completed NCT NCT02057172

    Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

    Not yet reported Hanmi Pharmaceutical Company Limited 254 participants Est. completion 2014-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02059564

    A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus

    Not yet reported Hanmi Pharmaceutical Company Limited 44 participants Est. completion 2014-12 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02060383

    Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly

    Not yet reported Novartis Pharmaceuticals 249 participants Est. completion 2018-03-26 43 sites Stand-alone
    Other conditions: Cushing's Disease, Acromegaly
    View official trial listing →
  • Terminated NCT NCT02072096

    A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)

    Not yet reported Eli Lilly and Company 192 participants Est. completion 2015-10 34 sites Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02073929

    LIPT - Liraglutide in Polycystic Ovary Syndrome

    Not yet reported Jens Faber 72 participants Est. completion 2015-12 3 sites
    Cardiovascular disease Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT02077946

    A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden

    Novo Nordisk A/S 1059 participants Est. completion 2014-09-03 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02082496

    GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations

    Not yet reported University of Copenhagen 50 participants Est. completion 2019-04 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02089256

    Effect of Repeated Administration of Liraglutide on Insulinogenic Indices

    Not yet reported University of Tartu 10 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02092896

    Liraglutide as add-on to Insulin in Type 1 Diabetes

    Not yet reported Hvidovre University Hospital 40 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02098395

    The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 835 participants Est. completion 2015-04 120 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02100475

    A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

    Not yet reported Novo Nordisk A/S 31 participants Est. completion 2015-04 60 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02104037

    Liraglutide in Spinal Fluid

    Not yet reported Mikkel Christensen 8 participants 1 site
    Other conditions: Liraglutide Blood-brain Transfer
    View official trial listing →
  • Withdrawn NCT NCT02109315

    Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes.

    Not yet reported Anna Cruceta Est. completion 2015-05 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02113332

    Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections

    Not yet reported Vastra Gotaland Region 124 participants Est. completion 2014-08 14 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02138045

    Treatment of Diabetic Neuropathy With Liraglutide

    Not yet reported Aalborg University Hospital 39 participants Est. completion 2017-02 1 site
    Other conditions: Diabetes Mellitus, Type 1, Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02140983

    Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes

    Not yet reported Stanford University 41 participants Est. completion 2017-02 1 site
    Other conditions: Insulin Resistance, Dementia
    View official trial listing →
  • Completed NCT NCT02147925

    Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects

    Not yet reported Sun Yat-sen University 75 participants Est. completion 2017-04 1 site
    Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Completed NCT NCT02150707

    The Differential Effects of Diabetes Therapy on Inflammation

    University College Dublin 17 participants Est. completion 2015-12 1 site
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
  • Completed NCT NCT02187250

    PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome

    Not yet reported University Medical Centre Ljubljana 45 participants Est. completion 2014-06 1 site
    Other conditions: PCOS, Obesity
    View official trial listing →
  • Withdrawn NCT NCT02198209

    Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation

    Not yet reported Cedars-Sinai Medical Center Est. completion 2020-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02201550

    Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide

    Hvidovre University Hospital 9 participants Est. completion 2014-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02205528

    A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

    Not yet reported Novo Nordisk A/S 108 participants Est. completion 2015-09-15 20 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02207348

    Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Terminated NCT NCT02231658

    Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion

    Not yet reported Profil Institut für Stoffwechselforschung GmbH 109 participants Est. completion 2018-07-23 2 sites Stand-alone
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02235961

    Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects

    Not yet reported Novo Nordisk A/S 163 participants Est. completion 2016-07-06 1 site Stand-alone
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Terminated NCT NCT02244164

    Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

    Not yet reported Erasme University Hospital 5 participants Est. completion 2023-02-13 1 site
    Type 2 diabetes Other conditions: Incretinomimetics, Pancreas
    View official trial listing →
  • Completed NCT NCT02255266

    Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice

    Novo Nordisk A/S 1788 participants Est. completion 2015-11-16 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Withdrawn NCT NCT02284230

    The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure

    Not yet reported Bo Feldt-Rasmussen Est. completion 2015-08 1 site
    Other conditions: Kidney Failure, Chronic, Prediabetic State
    View official trial listing →
  • Completed NCT NCT02292290

    Trial for People With Established Type 2 Diabetes During Ramadan

    Not yet reported University of Leicester 99 participants Est. completion 2012-12 2 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02298192

    A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

    Not yet reported Novo Nordisk A/S 420 participants Est. completion 2015-12-23 84 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02299388

    To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study

    Not yet reported Tulane University School of Medicine 11 participants Est. completion 2016-12 1 site
    Other conditions: Diabetes Mellitus, Non-Insulin-Dependent, Hypertensive Disease
    View official trial listing →
  • Completed NCT NCT02315001

    Liraglutide to Improve corONary Haemodynamics During Exercise streSS

    Not yet reported King's College London 26 participants Est. completion 2015-03 1 site
    Other conditions: Ischaemic Heart Disease, Coronary Heart Disease, Chronic Stable Angina
    View official trial listing →
  • Completed NCT NCT02321878

    Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)

    Novo Nordisk A/S 1092 participants Est. completion 2017-06-16 5 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02324842

    Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients

    Not yet reported The University of Texas Health Science Center at San Antonio 45 participants Est. completion 2019-03-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02344186

    Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes

    Not yet reported Temple University 12 participants Est. completion 2023-12-31 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02351232

    The Lira Pump Trial

    Not yet reported, Not yet reported Hvidovre University Hospital 44 participants Est. completion 2016-10 2 sites Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02403284

    The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans

    Not yet reported Phoenix VA Health Care System 97 participants Est. completion 2023-11-01 1 site Stand-alone
    Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT02408705

    Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects

    Not yet reported Medical University of Graz 14 participants Est. completion 2016-05 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT02417103

    Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid

    Not yet reported Universitätsklinikum Hamburg-Eppendorf 2 participants Est. completion 2016-12 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02420262

    A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 506 participants Est. completion 2016-10-05 117 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02423824

    Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists

    Not yet reported University Health Network, Toronto 21 participants Est. completion 2016-05 1 site
    Other conditions: Bipolar Disorder, Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT02443155

    A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

    Not yet reported Novo Nordisk A/S 308 participants Est. completion 2019-02-27 108 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02453711

    Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 957 participants Est. completion 2017-04-12 74 sites
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Completed NCT NCT02456428

    Incretin-based Drugs and the Risk of Heart Failure

    Canadian Network for Observational Drug Effect Studies, CNODES 1499650 participants Est. completion 2015-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02461589

    Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 706 participants Est. completion 2016-10-13 150 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Withdrawn NCT NCT02472717

    Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study

    Not yet reported University Health Network, Toronto Est. completion 2016-10 1 site Stand-alone
    PrediabetesType 2 diabetes Other conditions: Psoriatic Arthritis, Psoriasis
    View official trial listing →
  • Completed NCT NCT02473809

    The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function

    Not yet reported University of Aarhus 60 participants Est. completion 2017-10 1 site Stand-alone
    Other conditions: Diabetes Complications, Osteoporosis
    View official trial listing →
  • Completed NCT NCT02475499

    Incretin-based Drugs and Pancreatic Cancer

    Canadian Network for Observational Drug Effect Studies, CNODES 886172 participants Est. completion 2015-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02476760

    Incretin-based Drugs and Acute Pancreatitis

    Canadian Network for Observational Drug Effect Studies, CNODES 1417914 participants Est. completion 2015-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02483299

    Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome

    Not yet reported University Medical Centre Ljubljana 40 participants Est. completion 2015-04 1 site
    Other conditions: PCOS, Obesity
    View official trial listing →
  • Completed NCT NCT02488057

    Improving Beta Cell Function in Mexican American Women With Prediabetes

    Not yet reported Ohio State University 360 participants Est. completion 2019-03 4 sites
    Prediabetes
    View official trial listing →
  • Status unknown NCT NCT02490176

    Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters

    Not yet reported Chinese PLA General Hospital 50 participants Est. completion 2016-07 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Terminated NCT NCT02492763

    A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)

    Not yet reported Merck Sharp & Dohme LLC 176 participants Est. completion 2017-04-18 Stand-alone
    Other conditions: Type II Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02501161

    A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 1012 participants Est. completion 2018-10-03 143 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT02501850

    The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)

    Not yet reported Hospital Universitari Vall d'Hebron Research Institute 40 participants Est. completion 2015-10 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02503943

    Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes

    Not yet reported Third Affiliated Hospital of Third Military Medical University 90 participants Est. completion 2016-09 Stand-alone
    Type 2 diabetes Other conditions: Overweight, Obesity, Masked Hypertension
    View official trial listing →
  • Completed NCT NCT02505334

    A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.

    Not yet reported Novo Nordisk A/S 635 participants Est. completion 2017-11-09 47 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT02507128

    Effects of Glucagon Like Peptide-1 on No-reflow

    Not yet reported Chen Wei Ren, MD 190 participants Est. completion 2016-07 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02516657

    Liraglutide in Adolescents With Type 1 Diabetes

    Not yet reported University at Buffalo 5 participants Est. completion 2023-08-03 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02518945

    Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes

    Not yet reported University at Buffalo 26 participants Est. completion 2016-04 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02527200

    Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome

    Not yet reported Novo Nordisk A/S 56 participants Est. completion 2020-11-19 32 sites Stand-alone
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Completed NCT NCT02527993

    Treatment of Hypoglycemia Following Gastric Bypass Surgery

    Not yet reported Zealand University Hospital 11 participants Est. completion 2017-04-08 Added to GLP-1
    Other conditions: Hypoglycemia, Obesity, Surgery
    View official trial listing →
  • Status unknown NCT NCT02535299

    Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment

    Not yet reported Third Military Medical University 200 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: GLP-1；Metformin；Telomere-telomerase System；Par-4
    View official trial listing →
  • Completed NCT NCT02545738

    Antiproteinuric Effects of Liraglutide Treatment

    Not yet reported Steno Diabetes Center Copenhagen 32 participants Est. completion 2016-05 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT02577848

    GLP-1 on Non-ST-Segment Elevation Myocardial Infarction

    Not yet reported Chinese PLA General Hospital 90 participants Est. completion 2016-10 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02584582

    The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate

    Not yet reported, Not yet reported Hvidovre University Hospital 10 participants Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02602600

    Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis

    Not yet reported Eva Prescott 33 participants Est. completion 2017-04-18 1 site Stand-alone
    Other conditions: Microvascular Angina
    View official trial listing →
  • Completed NCT NCT02607306

    A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.

    Not yet reported Novo Nordisk A/S 819 participants Est. completion 2017-12-22 76 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02608853

    Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADER™ Trial Participants

    Novo Nordisk A/S 9999 participants Est. completion 2015-01 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT02611232

    Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults

    Not yet reported University of Oulu 42 participants Est. completion 2024-06 3 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02616003

    Preoperative Condition in Giant Obese Patients

    Not yet reported Sana Klinikum Offenbach 50 participants Est. completion 2018-04 1 site
    Other conditions: Morbid Obesity, Bariatric Surgery Candidate
    View official trial listing →
  • Completed NCT NCT02617654

    Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes

    Not yet reported Per-Ola Carlsson 18 participants Est. completion 2020-09 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02638805

    Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide

    Not yet reported Intarcia Therapeutics 136 participants Est. completion 2017-10 36 sites Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02647944

    Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity

    Not yet reported Mayo Clinic 40 participants Est. completion 2016-12-30 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02650206

    Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood

    Not yet reported Stanford University 56 participants Est. completion 2019-09-27 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type II, Diabetes Mellitus, Adult-Onset, Inflammation
    View official trial listing →
  • Status unknown NCT NCT02650596

    Effects of GLP-1 on Chronic Heart Failure

    Not yet reported Shi Yang 68 participants Est. completion 2018-02 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02654665

    Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults

    Not yet reported Changi General Hospital 36 participants Est. completion 2018-12 1 site Stand-alone
    MASLDMASH Other conditions: Weight Loss
    View official trial listing →
  • Completed NCT NCT02655770

    Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients

    Not yet reported Rigshospitalet, Denmark 40 participants Est. completion 2019-12 1 site
    Type 2 diabetes Other conditions: Diastolic Dysfunction, Cardiac MRI, Myocardial Perfusion
    View official trial listing →
  • Completed NCT NCT02660047

    Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent

    Not yet reported Leiden University Medical Center 51 participants Est. completion 2018-03-09 1 site
    Type 2 diabetesMetabolic syndromeCardiovascular disease Other conditions: Diastolic Dysfunction, Fatty Liver
    View official trial listing →
  • Terminated NCT NCT02674893

    Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes

    Not yet reported Centre Hospitalier Universitaire Dijon 48 participants Est. completion 2016-08-31 1 site Stand-alone
    Type 2 diabetes Other conditions: Overweight
    View official trial listing →
  • Completed NCT NCT02686177

    Effect of GLP-1 on Angiogenesis

    Not yet reported Assistance Publique - Hôpitaux de Paris 50 participants Est. completion 2021-05-28 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02696148

    A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2017-04-13 9 sites
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Completed NCT NCT02717858

    A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.

    Not yet reported Novo Nordisk A/S 52 participants Est. completion 2017-02-27 1 site Stand-alone
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Status unknown NCT NCT02718950

    Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans

    Not yet reported University of Campinas, Brazil 20 participants Est. completion 2017-04 Stand-alone
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Terminated NCT NCT02721888

    Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism

    Not yet reported Centre Hospitalier Universitaire Dijon 127 participants 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02730377

    Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 1991 participants Est. completion 2019-08-12 232 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT02743598

    Liraglutide for HIV-associated Neurocognitive Disorder

    Not yet reported Temple University 4 participants Est. completion 2018-09 1 site Stand-alone
    Type 2 diabetesMetabolic syndrome Other conditions: HIV Infection, Obesity, Overweight
    View official trial listing →
  • Completed NCT NCT02754817

    A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus

    Novo Nordisk A/S 611 participants Est. completion 2016-10-20 5 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02765399

    The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis

    Not yet reported Helsinki University Central Hospital 23 participants Est. completion 2019-02-28 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02773355

    Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients

    Novo Nordisk A/S 27 participants Est. completion 2022-02-28 14 sites
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02773368

    A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 420 participants Est. completion 2017-10-23 88 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02777073

    Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes

    Not yet reported University at Buffalo 43 participants Est. completion 2016-12-31 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT02783196

    Effect of Liraglutide on Clock Genes

    Not yet reported Tel Aviv University 14 participants Est. completion 2017-06 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02787551

    Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period

    Not yet reported Sanofi 514 participants Est. completion 2018-11-17 124 sites Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02832999

    Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes

    Not yet reported Yaounde Central Hospital 14 participants Est. completion 2016-12 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02863419

    Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 711 participants Est. completion 2018-03-30 108 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02870231

    Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity

    Not yet reported Novo Nordisk A/S 187 participants Est. completion 2017-09-03 2 sites Stand-alone
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Active, not recruiting NCT NCT02879409

    HbA1c Variability in Type II Diabetes

    Not yet reported Weill Cornell Medical College in Qatar 150 participants Est. completion 2026-10-01 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02889510

    Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus

    Not yet reported Lecube, Albert, M.D. 76 participants Est. completion 2019-12-16 6 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02895672

    GLP-1/Basal Insulin Combination Therapy

    Albany College of Pharmacy and Health Sciences 150 participants Est. completion 2016-12
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02898506

    Incretin-based Therapy in Late Preclinical Type 1 Diabetes

    Not yet reported University of Oulu 13 participants Est. completion 2021-06 4 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02905864

    Liraglutide 3 mg for Knee Osteoarthritis

    Not yet reported Henrik Gudbergsen 150 participants Est. completion 2019-03 1 site Stand-alone
    Osteoarthritis Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02908087

    Incretin-based Therapy in Early Diagnosed Type 1 Diabetes

    Not yet reported University of Oulu 13 participants Est. completion 2021-05 4 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02909933

    Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity

    Not yet reported University Medical Centre Ljubljana 30 participants Est. completion 2015-10 1 site Stand-alone
    Other conditions: Polycystic Ovary Syndrome, Obesity
    View official trial listing →
  • Completed NCT NCT02910570

    Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee Osteoarthritis

    Not yet reported Parker Research Institute 150 participants Est. completion 2019-03 1 site Stand-alone
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT02911818

    Lifestyle Modification and Liraglutide

    Not yet reported University of Pennsylvania 150 participants Est. completion 2018-12 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02911948

    A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs

    Not yet reported Novo Nordisk A/S 210 participants Est. completion 2017-11-22 38 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02918279

    Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity

    Not yet reported Novo Nordisk A/S 251 participants Est. completion 2019-08-08 33 sites Stand-alone
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Withdrawn NCT NCT02920190

    Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat

    Not yet reported University of Miami Est. completion 2021-12-31 Stand-alone
    Other conditions: Monoclonal Gammopathies, Overweight, Obesity
    View official trial listing →
  • Completed NCT NCT02928471

    Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss

    Henrik Gudbergsen 200 participants Est. completion 2019-03 1 site
    Osteoarthritis Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02928614

    Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Maintenance

    Not yet reported Henrik Gudbergsen 150 participants Est. completion 2019-03 1 site Stand-alone
    Osteoarthritis Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02928679

    Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance

    Not yet reported Henrik Gudbergsen 150 participants Est. completion 2019-03-20 1 site Stand-alone
    Osteoarthritis Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT02930265

    Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy

    Not yet reported Chinese PLA General Hospital 400 participants Est. completion 2018-03 1 site
    Other conditions: Ischemic Cardiomyopathy
    View official trial listing →
  • Status unknown NCT NCT02931344

    Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Loss

    Not yet reported Henrik Gudbergsen 200 participants Est. completion 2019-06 1 site
    Other conditions: Osteoarthrtis, Obesity
    View official trial listing →
  • Completed NCT NCT02931370

    Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss

    Henrik Gudbergsen 200 participants Est. completion 2019-03 1 site
    Osteoarthritis Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02931383

    Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance

    Not yet reported Henrik Gudbergsen 150 participants Est. completion 2019-03 1 site Stand-alone
    Osteoarthritis Other conditions: Obesity
    View official trial listing →
  • Active, not recruiting NCT NCT02944500

    Saxenda: Underlying Mechanisms and Clinical Outcomes

    Not yet reported Beth Israel Deaconess Medical Center 28 participants Est. completion 2027-06 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02953665

    Safety and Efficacy of Liraglutide in Parkinson's Disease

    Not yet reported Cedars-Sinai Medical Center 63 participants Est. completion 2022-08-03 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT02954627

    Ultrasound Assessment of the Carotid Intimal Medial Thickness in Obese Subjects; Weight Loss

    Henrik Gudbergsen 200 participants Est. completion 2019-03 1 site
    Osteoarthritis Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02960659

    Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes

    Not yet reported, Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24 participants Est. completion 2022-05-20 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02963922

    Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin

    Not yet reported Novo Nordisk A/S 396 participants Est. completion 2018-09-25 54 sites Stand-alone
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Completed NCT NCT02963935

    Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting

    Not yet reported Novo Nordisk A/S 282 participants Est. completion 2018-06-19 10 sites Stand-alone
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Completed NCT NCT02964247

    LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.

    Not yet reported Novo Nordisk A/S 303 participants Est. completion 2018-05-08 82 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02967757

    In-market Utilisation of Liraglutide Used for Weight Management in Europe

    Novo Nordisk A/S 316 participants Est. completion 2019-05-28 19 sites
    Other conditions: Metabolism and Nutrition Disorder, Obesity
    View official trial listing →
  • Completed NCT NCT02973321

    A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus

    Not yet reported Sanofi 296 participants Est. completion 2017-12-27 59 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03010683

    Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus

    Not yet reported University of Athens 60 participants Est. completion 2017-12 1 site
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03011008

    Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus

    Not yet reported Second Xiangya Hospital of Central South University 20 participants Est. completion 2021-06 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus, Autoimmune Diabetes
    View official trial listing →
  • Status unknown NCT NCT03011021

    Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes

    Not yet reported, Not yet reported Second Xiangya Hospital of Central South University 40 participants Est. completion 2025-06 1 site Stand-alone
    Other conditions: Type1 Diabetes Mellitus, Autoimmune Diabetes
    View official trial listing →
  • Completed NCT NCT03018028

    Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 243 participants Est. completion 2018-08-15 16 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03034941

    Short Term Weight Loss With Liraglutide and Metformin in Infertile Obese PCOS Patients

    Not yet reported University Medical Centre Ljubljana 35 participants Est. completion 2016-12 1 site
    Other conditions: Obesity, PCOS
    View official trial listing →
  • Completed NCT NCT03036800

    Saxenda in Obesity Services (STRIVE Study)

    Not yet reported University of Leicester 392 participants Est. completion 2022-02-25 5 sites Added to GLP-1
    Other conditions: Obesity, Weight Loss, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03038620

    Impact of Liraglutide 3.0 on Body Fat Distribution

    Not yet reported University of Texas Southwestern Medical Center 235 participants Est. completion 2020-10-13 1 site Stand-alone
    Cardiovascular disease Other conditions: Obesity, Visceral, Fat Disorder
    View official trial listing →
  • Completed NCT NCT03041792

    Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects

    Not yet reported Pfizer 61 participants Est. completion 2018-01-16 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03048578

    Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery

    Not yet reported NYU Langone Health 132 participants Est. completion 2021-03-02 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03068065

    Antidiabetic Effects on Intrahepatic Fat

    Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 87 participants Est. completion 2015-10 1 site
    Type 2 diabetes Other conditions: Non-Alcoholic Fatty Liver Disease
    View official trial listing →
  • Withdrawn NCT NCT03070704

    Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India

    Novo Nordisk A/S Est. completion 2019-08-16
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03101930

    Cardiovascular Effects of GLP-1 Receptor Activation

    Not yet reported Vanderbilt University Medical Center 329 participants Est. completion 2021-06-24 1 site Stand-alone
    Prediabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03115099

    A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes

    Not yet reported Eli Lilly and Company 80 participants Est. completion 2018-04-05 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03115424

    Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy

    Not yet reported Mayo Clinic 46 participants Est. completion 2024-05-30 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03151005

    The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

    Not yet reported Xinqiao Hospital of Chongqing 70 participants Est. completion 2021-04-23 1 site Stand-alone
    Other conditions: Polycystic Ovary Syndrome (PCOS), Overweight, Obesity
    View official trial listing →
  • Completed NCT NCT03158805

    Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)

    Not yet reported Lindner Center of HOPE 60 participants Est. completion 2023-01-01 1 site
    Other conditions: Bipolar Disorder, Obesity
    View official trial listing →
  • Completed NCT NCT03172494

    A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)

    Not yet reported Novo Nordisk A/S 720 participants Est. completion 2019-07-13 36 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03175120

    A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)

    Not yet reported Novo Nordisk A/S 453 participants Est. completion 2019-04-04 37 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03182426

    Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)

    Not yet reported, Not yet reported University of Alberta 22 participants Est. completion 2024-07-15 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03191396

    Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 577 participants Est. completion 2018-08-13 92 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT03208881

    Ultrasound Assessment of the Adventitia, Extra-media (EMT) and Veia Jugularis Interna Thickness

    Henrik Gudbergsen 80 participants Est. completion 2019-01 1 site
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT03225209

    Medically Reproducing Bariatric Surgery

    Not yet reported Moahad S Dar 5 participants Est. completion 2018-10-23 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03233178

    Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study

    LMC Diabetes & Endocrinology Ltd. 4000 participants Est. completion 2017-06 1 site
    Type 2 diabetesMASLD Other conditions: Fatty Liver
    View official trial listing →
  • Completed NCT NCT03235050

    A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes

    Not yet reported AstraZeneca 834 participants Est. completion 2019-06-14 119 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03260881

    Liraglutide Effects on Epicardial Fat Inflammatory Genes

    Not yet reported University of Miami 38 participants Est. completion 2024-09-05 1 site
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Terminated NCT NCT03279731

    Binge Eating Liraglutide Intervention

    Not yet reported Kelly Allison 36 participants Est. completion 2019-10-01 1 site
    Other conditions: Binge-Eating Disorder
    View official trial listing →
  • Completed NCT NCT03292185

    A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2018-01-02 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03341429

    Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response

    Not yet reported University College, London 70 participants Est. completion 2020-06-11 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03347890

    Reward Mechanisms in Obesity

    Not yet reported Zoltan Pataky 70 participants Est. completion 2020-03-30 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03353948

    The Effect of a Liraglutide on IVF in Obese PCOS

    Not yet reported University Medical Centre Ljubljana 30 participants Est. completion 2016-09-01
    Other conditions: Polycystic Ovary Syndrome, Obesity, Infertility, Female
    View official trial listing →
  • Withdrawn NCT NCT03371862

    Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)

    Not yet reported Imperial College London Est. completion 2020-09-30 1 site Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT03374956

    Individualized Obesity Pharmacotherapy

    Not yet reported Mayo Clinic 193 participants Est. completion 2022-05-26 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT03421119

    Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes

    Not yet reported Cinnagen 300 participants Est. completion 2019-12-01 Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03426085

    The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes

    Not yet reported Eastern Virginia Medical School 44 participants Est. completion 2020-08 1 site Stand-alone
    Other conditions: Autonomic Nervous System Diseases, Sweat Gland Diseases, Diabetic Neuropathy With Neurologic Complication
    View official trial listing →
  • Completed NCT NCT03449654

    Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes

    Not yet reported Steno Diabetes Center Copenhagen 102 participants Est. completion 2019-08-16 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03466021

    Effects of Liraglutide in Chronic Obstructive Pulmonary Disease

    Not yet reported Claus Bogh Juhl 40 participants Est. completion 2020-05-31 2 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT03479762

    In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database

    Novo Nordisk A/S 105 participants Est. completion 2022-09-12 1 site
    Other conditions: Obesity, Overweight
    View official trial listing →
  • Completed NCT NCT03480022

    Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS

    Not yet reported Woman's 88 participants Est. completion 2021-05-19 1 site Stand-alone
    Other conditions: Pre Diabetes, Polycystic Ovary Syndrome, Obesity Android
    View official trial listing →
  • Completed NCT NCT03486392

    A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants

    Not yet reported Janssen Research & Development, LLC 474 participants Est. completion 2019-03-08 51 sites
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03492580

    A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease

    Janssen Research & Development, LLC 714582 participants Est. completion 2018-06-25 1 site
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Completed NCT NCT03498001

    Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging

    Not yet reported Centre Hospitalier Universitaire Dijon 42 participants Est. completion 2023-12-20 1 site Stand-alone
    Other conditions: Type II Diabetes
    View official trial listing →
  • Terminated NCT NCT03500484

    Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.

    Not yet reported Yale University 13 participants Est. completion 2020-06-25 1 site Stand-alone
    Other conditions: Obesity, Childhood, Neural Development
    View official trial listing →
  • Completed NCT NCT03520062

    The Effect of Liraglutide on Pancreatic Hormones and Its Size

    Not yet reported Nicolai Jacob Wewer Albrechtsen 14 participants Est. completion 2020-01-01 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03523273

    Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity

    Not yet reported Michael Camilleri, MD 136 participants Est. completion 2021-08-31 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03534310

    Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg

    Not yet reported Catholic University of the Sacred Heart 75 participants Est. completion 2017-04-10 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03555994

    A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.

    Not yet reported MedImmune LLC 51 participants Est. completion 2021-04-14 3 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03560336

    A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.

    Novo Nordisk A/S 758 participants Est. completion 2020-12-02 28 sites
    Other conditions: Obesity, Overweight
    View official trial listing →
  • Completed NCT NCT03619330

    Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.

    Not yet reported University Medical Centre Ljubljana 30 participants Est. completion 2015-08 1 site
    Other conditions: Hypogonadism, Obesity
    View official trial listing →
  • Completed NCT NCT03632759

    Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D

    Not yet reported Carla Greenbaum, MD 16 participants Est. completion 2021-11-09 2 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03642600

    The Gut Microbiome in Women With Polycystic Ovary Syndrome

    Not yet reported Universitaire Ziekenhuizen KU Leuven 21 participants Est. completion 2020-07-03 1 site
    Metabolic syndrome Other conditions: PCOS, Obesity
    View official trial listing →
  • Status unknown NCT NCT03671733

    Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients

    Not yet reported Xiangya Hospital of Central South University 150 participants Est. completion 2022-09-01 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03672812

    The Use of Liraglutide in Brain Death

    Not yet reported Hospital de Clinicas de Porto Alegre 50 participants Est. completion 2022-02-10 1 site Stand-alone
    Other conditions: Brain Death
    View official trial listing →
  • Completed NCT NCT03707171

    Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus

    Not yet reported Third Military Medical University 30 participants Est. completion 2019-05-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03712098

    Daily Liraglutide for Nicotine Dependence

    Not yet reported Rebecca Ashare 40 participants Est. completion 2022-05-25 1 site Stand-alone
    Other conditions: Smoking Cessation, Weight, Body
    View official trial listing →
  • Completed NCT NCT03737240

    IDegLira HIGH Trial

    Not yet reported Emory University 145 participants Est. completion 2022-07-08 2 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03757130

    Multiple Ascending Dose Study of AMG 598 in Adults With Obesity

    Not yet reported Amgen 50 participants Est. completion 2019-12-16 4 sites Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03795701

    To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity

    Not yet reported Texas Tech University 73 participants Est. completion 2022-05-01 2 sites Added to GLP-1
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03799198

    Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity

    Not yet reported Novo Nordisk A/S 200 participants Est. completion 2020-05-22 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT03804411

    Prognostic Predictors of Response to Hypoglycemic Therapy

    Not yet reported Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 800 participants Est. completion 2020-05 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03823339

    A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab Emirates

    Novo Nordisk A/S 300 participants Est. completion 2020-12-14 3 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03856047

    Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.

    Not yet reported Novo Nordisk A/S 706 participants Est. completion 2021-03-25 54 sites
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Active, not recruiting NCT NCT03856632

    Liraglutide Effect in Atrial Fibrillation

    Not yet reported University of Miami 60 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT03862716

    Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira

    Not yet reported Population Health Research Institute 159 participants Est. completion 2023-07-31 8 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03885297

    3mg Liraglutide for Overweight or Obesity

    University Hospitals Coventry and Warwickshire NHS Trust 43 participants Est. completion 2020-12-18 1 site
    Other conditions: Overweight, Obesity, Infertility, Female
    View official trial listing →
  • Completed NCT NCT03888157

    A Research Study Looking at How Victoza® Works in People With Type 2 Diabetes in Iran, Followed in Local Clinical Routine

    Novo Nordisk A/S 839 participants Est. completion 2020-10-21 16 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03936049

    Replication of the LEADER Diabetes Trial in Healthcare Claims

    Brigham and Women's Hospital 168690 participants Est. completion 2021-02-18 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT03948347

    Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus

    Not yet reported First Affiliated Hospital of Jinan University 1708 participants Est. completion 2024-06 1 site
    Cardiovascular diseaseType 2 diabetes Other conditions: Transient Ischemic Attack
    View official trial listing →
  • Completed NCT NCT03955575

    Treatment of Bile Acid Malabsorption With Liraglutide

    Not yet reported Filip Krag Knop 52 participants Est. completion 2022-05-31 1 site
    Other conditions: Bile Acid Malabsorption
    View official trial listing →
  • Status unknown NCT NCT03959865

    GLP-1 REceptor Agonists and Real World EvIdeNce

    University of Padova 6000 participants Est. completion 2019-05-31 6 sites
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03986008

    Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients

    Not yet reported Xiangya Hospital of Central South University 60 participants Est. completion 2021-12-23 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03993132

    A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes

    Boehringer Ingelheim 26774 participants Est. completion 2022-06-16 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04008290

    The Effect of Liraglutide on the GIT

    Not yet reported Universitaire Ziekenhuizen KU Leuven 15 participants Est. completion 2021-04-01 Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT04027023

    Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

    Not yet reported Sciema UG 9 participants Est. completion 2021-05-31 2 sites
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04034524

    Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin

    Brigham and Women's Hospital 20000 participants Est. completion 2020-12-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04046822

    Effect of Liraglutide on Microbiome in Obesity

    Not yet reported Federico II University 70 participants Est. completion 2020-04-30 1 site
    Other conditions: Obesity, Weight Loss, Microbiome
    View official trial listing →
  • Withdrawn NCT NCT04057261

    Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease

    Not yet reported RWTH Aachen University Est. completion 2022-11 1 site
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Completed NCT NCT04074161

    Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity

    Not yet reported Novo Nordisk A/S 338 participants Est. completion 2021-05-11 19 sites
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Status unknown NCT NCT04122716

    Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet

    Not yet reported Signe Torekov 215 participants Est. completion 2021-11 1 site
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT04137328

    Clinical Study on the Improvement of Diabetic Neuropathic Pain by Liraglutide

    Not yet reported Fudan University 60 participants Est. completion 2022-11-30 Stand-alone
    Other conditions: Diabetic Neuropathic Pain
    View official trial listing →
  • Status unknown NCT NCT04146155

    Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 200 participants Est. completion 2021-12-31 1 site Stand-alone
    Type 2 diabetes Other conditions: Peripheral Vascular Disorder Due to Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT04184947

    Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists

    University of Padova 10000 participants Est. completion 2020-02-29 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04186494

    Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea

    Not yet reported St Vincent's University Hospital, Ireland 30 participants Est. completion 2022-07-31 1 site Stand-alone
    Other conditions: Sleep Apnea, Obstructive
    View official trial listing →
  • Completed NCT NCT04190160

    Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)

    Not yet reported Stefano Rizza 35 participants Est. completion 2021-03-25 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04196231

    Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)

    Not yet reported University of Campania Luigi Vanvitelli 258 participants Est. completion 2020-10-20 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04199728

    Use of a GLP-1R Agonist to Treat Opioid Use Disorder

    Not yet reported, Not yet reported Milton S. Hershey Medical Center 27 participants Est. completion 2023-09-13 1 site Stand-alone
    Other conditions: Opiate Substitution Treatment, Opioid-Related Disorders
    View official trial listing →
  • Completed NCT NCT04311411

    A Study of Tirzepatide in Overweight and Very Overweight Participants

    Not yet reported Eli Lilly and Company 114 participants Est. completion 2022-12-16 3 sites
    Other conditions: Obesity, Overweight
    View official trial listing →
  • Active, not recruiting NCT NCT04324229

    Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes

    Not yet reported Turku University Hospital 80 participants Est. completion 2027-12 1 site
    Other conditions: Gestational Diabetes
    View official trial listing →
  • Completed NCT NCT04325581

    Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese Patients

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 16 participants Est. completion 2018-12-31 Stand-alone
    Other conditions: Weight Loss
    View official trial listing →
  • Status unknown NCT NCT04373967

    Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 424 participants Est. completion 2021-12-02 46 sites
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04417582

    Life Style Modification Medical and Surgical Management in Patients With Obesity

    Marmara University 1000 participants Est. completion 2025-12-01 1 site
    Other conditions: Obesity, Weight Change, Body, Obesity; Endocrine, Obesity, Metabolically Benign
    View official trial listing →
  • Status unknown NCT NCT04487743

    Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities

    Not yet reported Xiangya Hospital of Central South University 300 participants Est. completion 2022-06 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT04525300

    Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities

    Not yet reported Xiangya Hospital of Central South University 300 participants Est. completion 2022-06 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT04529278

    Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients

    Not yet reported Fondation Hôpital Saint-Joseph 18 participants Est. completion 2023-12-31 4 sites Stand-alone
    Type 2 diabetes Other conditions: Hemodialysis, Obese
    View official trial listing →
  • Terminated NCT NCT04531176

    EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial

    Not yet reported The Cleveland Clinic 74 participants Est. completion 2023-08-04 1 site Stand-alone
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT04535960

    Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial

    Not yet reported University Health Network, Toronto 36 participants Est. completion 2023-10 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04575194

    Study of the Cardiometabolic Effects of Obesity Pharmacotherapy

    Not yet reported National and Kapodistrian University of Athens 40 participants Est. completion 2023-05-30 1 site
    Other conditions: Obesity, Blood Pressure
    View official trial listing →
  • Completed NCT NCT04605861

    The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients

    Not yet reported Shanghai Zhongshan Hospital 414 participants Est. completion 2023-04-15 1 site Stand-alone
    Other conditions: Obese, Overweight
    View official trial listing →
  • Withdrawn NCT NCT04643301

    Liraglutide for Low-responders After Bariatric Surgery

    Not yet reported Zuyderland Medisch Centrum Est. completion 2021-12-31 Stand-alone
    Other conditions: Obesity, Obesity, Morbid
    View official trial listing →
  • Completed NCT NCT04657939

    Targeting Beta-cell Failure in Lean Patients With Type 2 Diabetes

    Not yet reported University of Leeds 57 participants Est. completion 2022-10-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04666987

    A Research Study Looking at Long-term Blood Sugar Control in People With Type 2 Diabetes Being Treated With Xultophy® in a Real-world Setting in Italy

    Novo Nordisk A/S 359 participants Est. completion 2023-02-10 28 sites
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT04683237

    Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia

    Not yet reported, Not yet reported Xiaojun Chen Est. completion 2026-11-30 Stand-alone
    Other conditions: Atypical Endometrial Hyperplasia, Obese, Fertility Issues
    View official trial listing →
  • Terminated NCT NCT04763564

    Efficacy of Liraglutide Therapy in Patients With IPAA

    Not yet reported University of North Carolina, Chapel Hill 8 participants Est. completion 2023-10-16 1 site Stand-alone
    Other conditions: Pouchitis, Irritable Pouch Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT04775082

    SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity

    Not yet reported Novo Nordisk A/S 78 participants Est. completion 2027-02-08 32 sites Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT04781998

    Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?

    Not yet reported Anders Fink-Jensen, MD, DMSci 24 participants Est. completion 2022-09-01 1 site Stand-alone
    Other conditions: Mental Disorder, Metabolic Disturbance, Feasibility, Overweight and Obesity, Liraglutide
    View official trial listing →
  • Completed NCT NCT04829903

    Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin

    Not yet reported Corporacion Parc Tauli 116 participants Est. completion 2021-11-20 1 site
    Type 2 diabetes Other conditions: Obesity, Adolescent Obesity
    View official trial listing →
  • Withdrawn NCT NCT04839237

    The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients

    Not yet reported Xiangya Hospital of Central South University Est. completion 2021-12-01 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT04881110

    Liraglutide and Peripheral Artery Disease

    Not yet reported University of Campania Luigi Vanvitelli 60 participants Est. completion 2022-12-31 1 site Stand-alone
    Type 2 diabetes Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT04883346

    Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 34 participants Est. completion 2024-04-30 1 site Stand-alone
    Other conditions: Obesity, Status Post Sleeve Gastrectomy
    View official trial listing →
  • Completed NCT NCT04903509

    A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide

    Not yet reported Boehringer Ingelheim 95 participants Est. completion 2022-08-26 1 site Added to GLP-1
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04952779

    Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

    Novo Nordisk A/S 750 participants Est. completion 2024-12-15 32 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05029076

    Human Bioequivalence Test of Liraglutide Injection

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 28 participants Est. completion 2019-07-01 1 site Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05041673

    Anti-diabetic Drugs and Fatty Liver Management

    Not yet reported Alexandria University 120 participants Est. completion 2022-09-30 1 site Stand-alone
    Type 2 diabetes Other conditions: Fatty Liver, Nonalcoholic
    View official trial listing →
  • Completed NCT NCT05073692

    Comparison of Type 2 Diabetes Pharmacotherapy Regimens

    Kaiser Permanente 241981 participants Est. completion 2025-03-12 6 sites
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Completed NCT NCT05111912

    Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

    Not yet reported Sciwind Biosciences APAC CO Pty. Ltd. 206 participants Est. completion 2022-12-20 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT05136287

    SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.

    Jose Seijas Amigo 140 participants Est. completion 2024-01-01 11 sites
    Type 2 diabetes Other conditions: Weight Loss, Quality of Life, Safety Issues
    View official trial listing →
  • Completed NCT NCT05153590

    A Research Study About Weight Loss and Treatment Patterns With the Use of Saxenda® in Adults in Real-life Settings in Switzerland

    Novo Nordisk A/S 269 participants Est. completion 2022-04-15 1 site
    Other conditions: Obesity or Overweight
    View official trial listing →
  • Status unknown NCT NCT05161429

    BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

    Brigham and Women's Hospital 550000 participants Est. completion 2024-06-30 5 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05162183

    Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data

    Brigham and Women's Hospital 3474 participants Est. completion 2021-09-01 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT05220917

    Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study

    Brigham and Women's Hospital 781430 participants Est. completion 2027-09-30 1 site
    Type 2 diabetes Other conditions: Cardiovascular Events, Renal Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05221229

    Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )

    University Hospital Birmingham 29 participants Est. completion 2026-06-01 1 site
    Other conditions: Atrial Fibrillation, Recurrence, Overweight and Obesity, Liraglutide
    View official trial listing →
  • Completed NCT NCT05225974

    A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects

    Not yet reported The Affiliated Hospital of Qingdao University 32 participants Est. completion 2021-08-19 1 site Stand-alone
    Other conditions: Therapeutic Equivalency
    View official trial listing →
  • Status unknown NCT NCT05268627

    Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss

    Not yet reported Mansoura University 38 participants Est. completion 2023-01-27 2 sites
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT05285397

    Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.

    Not yet reported General Committee of Teaching Hospitals and Institutes, Egypt 60 participants Est. completion 2022-09 1 site Stand-alone
    Other conditions: Morbid Obesity
    View official trial listing →
  • Completed NCT NCT05294536

    A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects

    Not yet reported Sunshine Lake Pharma Co., Ltd. 50 participants Est. completion 2020-11-27 1 site Mixed
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05313529

    LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes

    Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 396 participants Est. completion 2026-07-01 5 sites Stand-alone
    Type 2 diabetes Other conditions: Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT05360147

    Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus

    Not yet reported Third Military Medical University 30 participants Est. completion 2021-05-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05360537

    Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients

    Not yet reported University of Palermo 100 participants Est. completion 2022-04-20 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05390307

    Obesity Treatment to Improve Diabetes

    Not yet reported Dasman Diabetes Institute 60 participants Est. completion 2024-01-01 1 site Mixed
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT05419856

    Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee

    Not yet reported 4Moving Biotech 34 participants Est. completion 2023-10-31 3 sites
    Osteoarthritis
    View official trial listing →
  • Withdrawn NCT NCT05438186

    INSPIRE Turkey :A Research Study Looking at the Clinical Parameters Associated With Use and Discontinuation of Saxenda® in Local Clinical Practice in Turkey by Analysing Past Patient Medical Records

    Novo Nordisk A/S Est. completion 2022-10-31 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT05444569

    A Study of LY3537021 in Healthy Participants

    Not yet reported Eli Lilly and Company 47 participants Est. completion 2023-02-24 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05467514

    Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus

    Not yet reported David Sanchez Garcia 35 participants Est. completion 2023-02-28 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Withdrawn NCT NCT05479591

    A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia

    Novo Nordisk A/S Est. completion 2023-04-30
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05492305

    Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health

    King's College London 20 participants Est. completion 2023-08 1 site
    Other conditions: Diabetes Mellitus, Obesity, Mental Health Issue
    View official trial listing →
  • Status unknown NCT NCT05545800

    Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy

    Not yet reported Xiangya Hospital of Central South University 78 participants Est. completion 2024-06-01 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05579249

    A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America

    Not yet reported Novo Nordisk A/S 500 participants Est. completion 2024-11-27 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT05598008

    Effects of Glucagon-like-Peptide-1 Analogues on Sexuality

    University Hospital, Basel, Switzerland 85 participants Est. completion 2025-10-24 1 site
    Other conditions: Sexual Desire
    View official trial listing →
  • Status unknown NCT NCT05705388

    POSE2.0 With GLP-1 Agonist for Obesity Management

    Not yet reported Emirates Health Services (EHS) 50 participants Est. completion 2026-01-03 1 site
    Other conditions: Obesity
    View official trial listing →
  • Active, not recruiting NCT NCT05756764

    Anti-obesity Pharmacotherapy and Inflammation

    Louisiana State University Health Sciences Center in New Orleans 30 participants Est. completion 2026-02-20 2 sites
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT05767255

    Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue

    Not yet reported Hospital Universitario San Ignacio 66 participants Est. completion 2023-08-30 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05779644

    Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus

    Not yet reported RenJi Hospital 300 participants Est. completion 2025-02-23 1 site Stand-alone
    Type 2 diabetes Other conditions: Metformin, Obesity, Abdominal, Abdominal Fat, Non-Alcoholic Fatty Liver Disease, Metabolism Disorder, Glucose, Metabolism Disorder, Lipid
    View official trial listing →
  • Completed NCT NCT05794581

    A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes

    Not yet reported Carmot Therapeutics, Inc. 32 participants Est. completion 2024-04-06 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT05812183

    Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity

    Not yet reported University of California, Los Angeles Est. completion 2025-02-12 Stand-alone
    Other conditions: Dyspnea, Quality of Life
    View official trial listing →
  • Status unknown NCT NCT05952882

    Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

    Not yet reported Mỹ Đức Hospital 188 participants Est. completion 2025-12-31
    Other conditions: Polycystic Ovary Syndrome, Obesity, Infertility, Female
    View official trial listing →
  • Completed NCT NCT05965908

    Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome

    Not yet reported Beni-Suef University 183 participants Est. completion 2025-12-30 1 site Stand-alone
    Other conditions: Polycystic Ovary
    View official trial listing →
  • Completed NCT NCT06099067

    Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)

    AstraZeneca 239990 participants Est. completion 2023-08-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06120556

    Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes

    Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 130 participants Est. completion 2023-10-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Suspended NCT NCT06171152

    Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

    Not yet reported University of Chicago 30 participants Est. completion 2027-10-01 1 site Stand-alone
    Other conditions: Multiple Sclerosis, Long COVID, Long Covid19, Obese, Obesity, Obesity, Morbid, Acute Leukemia in Remission
    View official trial listing →
  • Completed NCT NCT06201819

    Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery

    Not yet reported Hospital Civil Juan I. Menchaca 37 participants Est. completion 2023-05-01 1 site Stand-alone
    Other conditions: Weight Loss, Bariatric Surgery Candidate, Obesity, Morbid
    View official trial listing →
  • Status unknown NCT NCT06217848

    The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

    Not yet reported Seoul National University Hospital 50 participants Est. completion 2024-03-08 1 site Added to GLP-1
    Other conditions: Panhypopituitarism, Craniopharyngioma, Hypothalamic Obesity
    View official trial listing →
  • Completed NCT NCT06283641

    Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.

    Novo Nordisk A/S 300 participants Est. completion 2025-01-13 15 sites
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06400615

    Study That Tests AD109 in Patients Taking GLP-1 Drugs

    Not yet reported Apnimed 40 participants Est. completion 2024-12-26 4 sites
    Obstructive sleep apnea
    View official trial listing →
  • Status unknown NCT NCT06408532

    The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes

    Not yet reported Peking University People's Hospital 256 participants Est. completion 2025-02-28
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT06438146

    LIROH - Liraglutide for Obesity in HIV

    Not yet reported Brigham and Women's Hospital 40 participants Est. completion 2025-05 1 site Stand-alone
    Other conditions: Obesity, HIV Infections
    View official trial listing →
  • Completed NCT NCT06439056

    Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D

    Not yet reported Nanexa AB 12 participants Est. completion 2025-07-18 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT06449235

    Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh

    Not yet reported Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders 938 participants Est. completion 2025-06 1 site
    Other conditions: Type2diabetes
    View official trial listing →
  • Status unknown NCT NCT06449703

    A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese Subjects

    Not yet reported Tonghua Dongbao Pharmaceutical Co.,Ltd 44 participants Est. completion 2024-06-16 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06482411

    Risk Factors Affect Weight Loss Outcomes After Treatment.

    E-DA Hospital 3602 participants Est. completion 2025-10-22 1 site
    Other conditions: Weight Regain
    View official trial listing →
  • Completed NCT NCT06500130

    Effects of Liraglutide on Body Surface Gastric Mapping

    Not yet reported Alimetry 22 participants Est. completion 2024-11-30 1 site Stand-alone
    Other conditions: Gastroparesis, Functional Dyspepsia, Chronic Nausea and Vomiting Syndrome, Healthy
    View official trial listing →
  • Status unknown NCT NCT06501326

    Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease

    Not yet reported Affiliated Hospital of Nantong University 102 participants Est. completion 2025-02-28 1 site Stand-alone
    Other conditions: Non-alcoholic Fatty Liver Disease, Obesity
    View official trial listing →
  • Completed NCT NCT06533527

    Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy

    Not yet reported The Cleveland Clinic 69 participants Est. completion 2025-05-20 2 sites
    Type 2 diabetes Other conditions: Obesity, Gastroparesis
    View official trial listing →
  • Status unknown NCT NCT06559722

    A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes

    Not yet reported Tonghua Dongbao Pharmaceutical Co.,Ltd 510 participants Est. completion 2026-02 Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Enrolling by invitation NCT NCT06581120

    GLP_1 RA Ultrasound Study

    Children's Hospital Medical Center, Cincinnati 100 participants Est. completion 2026-07 1 site
    Other conditions: Glucagon Like Peptide-1 (GLP-1, Delayed Gastric Emptying, Risk of Aspiration, Diabetes, Morbid Obesity
    View official trial listing →
  • Completed NCT NCT06818292

    Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists

    Not yet reported Nils Opel 10 participants Est. completion 2024-12-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Not yet recruiting NCT NCT06865365

    Preoperative Use of Liraglutide Additionally to Common Dietological Measures as Opposed to Dietological Measures Alone

    Not yet reported Medical University of Vienna 72 participants Est. completion 2028-02-01 Stand-alone
    Other conditions: Obesity, Adolescent
    View official trial listing →
  • Enrolling by invitation NCT NCT06925334

    A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus

    Not yet reported Beijing Tsinghua Chang Gung Hospital 170 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Type 2 Diabetic Patients
    View official trial listing →
  • Not yet recruiting NCT NCT07027969

    Metabolic Surgery for Atrial Fibrillation Elimination

    Not yet reported Ali Aminian 100 participants Est. completion 2030-03-31 1 site
    Other conditions: Atrial Fibrillation, Obesity and Obesity-related Medical Conditions
    View official trial listing →
  • Active, not recruiting NCT NCT07188545

    Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)

    Ohio State University 23280000 participants Est. completion 2029-06-30 1 site
    Metabolic syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT07225829

    A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis

    Not yet reported 4Moving Biotech 129 participants Est. completion 2026-09 22 sites
    Osteoarthritis Other conditions: Synovitis of Knee
    View official trial listing →
  • Not yet recruiting NCT NCT07301437

    RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.

    Not yet reported The Fourth Affiliated Hospital of Zhejiang University School of Medicine 120 participants Est. completion 2027-08-31 Stand-alone
    Other conditions: Overweight and Obese Adults
    View official trial listing →
  • Completed NCT NCT07304141

    Pharmacological Treatment - An Overview of Its Role in Managing Childhood Obesity

    Göteborg University 128 participants Est. completion 2025-12-12 1 site
    Other conditions: Obesity (Disorder), Child Obesity
    View official trial listing →
  • Active, not recruiting NCT NCT07325435

    Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists

    Not yet reported MaryAnn Banerji 60 participants Est. completion 2028-06-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT07374445

    Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery

    Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 100 participants Est. completion 2025-06-01 1 site Stand-alone
    Other conditions: Obesity, Weight Loss, Bariatric Surgery
    View official trial listing →
  • Completed NCT NCT07539584

    Adiponectin in Patients With Metabolic Disorders

    Not yet reported Moscow Regional Research and Clinical Institute (MONIKI) 130 participants Est. completion 2024-04-08 1 site Stand-alone
    Type 2 diabetes Other conditions: Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
    View official trial listing →
  • Active, not recruiting NCT NCT07590219

    Use of Liraglutide in Children Aged 6 to 12 Years With Severe Obesity

    Not yet reported University of Sao Paulo General Hospital 30 participants Est. completion 2028-04 1 site Stand-alone
    Other conditions: Severe Obesity, Cardiovascular Function, Liraglutide, Childhood Obesity, Echocardiography, Speckle Tracking
    View official trial listing →
  • Enrolling by invitation NCT NCT07640139

    Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes

    Indiana University 125000 participants Est. completion 2029-12-31 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT07677865

    GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation

    West China Hospital 213891 participants Est. completion 2026-06-24 1 site
    Type 2 diabetes Other conditions: Alzheimer Disease, Obesity & Overweight
    View official trial listing →
  • Not yet recruiting NCT NCT07787936

    GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry

    Miedziowe Centrum Zdrowia SA 150 participants Est. completion 2033-01-01 1 site
    Heart failure Other conditions: Obesity, Pulmonary Hypertension, Iron Deficiency
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Liraglutide, Liraglutide (GLP-1RA), liraglutide (Novo Nordisk, Bagsværd, Denmark), Liraglutide injection

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.